Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer.

He J, Hu Y, Hu M, Li B. · 2015

Read Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer. by He J, Hu Y, Hu M, Li B. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4538573.txt.

Description

Jiabei He, Ying Hu, Mingming Hu, and Baolan Li review an immune escape route in lung cancer, in Scientific Reports in 2015. Non-small cell lung cancer makes up about 85% of lung cancers, the world's top cancer killer. Surgery, chemotherapy, targeted drugs, and radiation still leave poor outlooks, so new angles are needed.

Tumors exploit the PD-1/PD-L1 pathway, a brake that normally keeps immune cells from over-firing. By engaging that brake, cancer cells hide from attack and shape a friendly local setting. Blocking it can release the body's own antitumor response, and early trials in this lung cancer showed gains. The review covers the pathway's biology, the inhibitors in development, and the open problems for wider use.

Catalog record

CREATORHe J, Hu Y, Hu M, Li B.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4538573

Browse the full library · About the Tower of Babel